Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学RCC Belzutifan/HIF-2

Toni Choueiri

MD

🏢Dana-Farber Cancer Institute🌐USA

Director, Lank Center for Genitourinary Oncology

135
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Toni Choueiri is the foremost leader in renal cell carcinoma research and has been principal investigator of pivotal belzutifan trials in both VHL disease and advanced RCC. His clinical trials have established new treatment paradigms including IO-TKI combinations and HIF-2alpha inhibition. He has transformed the therapeutic landscape for kidney cancer patients worldwide.

Share:

🧪Research Fields 研究领域

Renal cell carcinoma
Belzutifan
HIF-2 alpha inhibition
Immunotherapy combinations
Biomarker development

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Toni Choueiri 的研究动态

Follow Toni Choueiri's research updates

留下邮箱,当我们发布与 Toni Choueiri(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment